|
1 |
Impact of intensified contact precautions while treating hematopoietic stem cell transplantation recipients during aplasia
Böing, Christian Wilhelm. - Münster : Universitäts- und Landesbibliothek Münster, 2025
|
|
|
|
2 |
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis
Shaforostova, Inna. - Münster : Universitäts- und Landesbibliothek Münster, 2025
|
|
|
|
3 |
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
Lübke, Johannes. - Aachen : Universitätsbibliothek der RWTH Aachen, 2024
|
|
|
|
4 |
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
Schöfbänker, Michael. - Münster : Universitäts- und Landesbibliothek Münster, 2024
|
|
|
|
5 |
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Kunadt, Désirée. - Dresden : Technische Universität Dresden, 2024
|
|
|
|
6 |
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Stelljes, Matthias. - Augsburg : Universität Augsburg, 2024
|
|
|
7 |
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Enthalten in Bone marrow transplantation 19.12.2024: 1-7
|
|
|
|
8 |
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Enthalten in Bone marrow transplantation 12.11.2024: 1-7
|
|
|
|
9 |
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients
Enthalten in Bone marrow transplantation 3.5.2024: 1-10
|
|
|
|
10 |
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
Enthalten in Bone marrow transplantation 25.4.2024: 1-8
|
|
Administration
